Theravance Biopharma, Inc. (TBPH)

Highly Crowded

Held by 163 of 5,944 reporting institutions (90th percentile) — extremely crowded.

Data as of Q1 2026

Institutional Ownership

96.57%

QoQ Change

+1.44%

Total Value

$778.2B

Shares Outstanding

51.6M

Crowding AnalysisHighly Crowded

Holders163of 5,944

Avg: 68

Uncrowded90th percentileCrowded

Institutional Activity

Buy/Sell Ratio1.18x

77th percentile

100 buying85 selling

+40

New

-38

Closed

+840K

Net shares

Holding Period Distribution

estimate

Median: 3 QAvg: 2.8 QHolders: 163

Ownership Concentration

Top 5: 58.0%Top 10: 71.5%

Madison Avenue Partners,19.1%

Weiss Asset Management15.0%

Newtyn Management,9.7%

BlackRock,8.6%

Irenic Capital Management5.5%

Others (158)42.0%

Loading crowding analysis...

Conviction-Weighted Ownership

Median weight: 0.02%Avg weight: 2.01%Max: 8.40%High conviction (>1%): 4

Madison Avenue Partners,

Weiss Asset Management

Newtyn Management,

BlackRock,

Irenic Capital Management

VANGUARD CAPITAL MANAGEMENT

STATE STREET

ACADIAN ASSET MANAGEMENT

TWO SIGMA INVESTMENTS,

GEODE CAPITAL MANAGEMENT,

Loading conviction analysis...

Whale Moves Timeline (8 Quarters)

Biggest dollar-value position changes among top 10 holders

NEWVANGUARD CAPITAL MANAGEMENT$29M1.8M shr

NEWTWO SIGMA INVESTMENTS$20M1.3M shr

NEWGEODE CAPITAL MANAGEMENT$18M1.1M shr

BOUGHTNewtyn Management$9M542K shr

BOUGHTBlackRock$4M246K shr

BOUGHTACADIAN ASSET MANAGEMENT$1.4B77K shr

NEWSTATE STREET$21M1.1M shr

NEWARROWSTREET CAPITAL, LIMITED PARTNERSHIP$18M963K shr

SOLDNewtyn Management$12M650K shr

BOUGHTVANGUARD GROUP$3M156K shr

Loading whale moves...

Institutional Trends (8 Quarters)

Loading ownership trends...

Institutional Holders

Loading top holders...